日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Erdafitinib or Erdafitinib Plus Cetrelimab for Patients With Metastatic Urothelial Carcinoma and FGFR Alterations: Final Results From the Phase II NORSE Study

厄达替尼或厄达替尼联合西曲利单抗治疗伴有FGFR改变的转移性尿路上皮癌患者:II期NORSE研究的最终结果

Loriot, Yohann; Powles, Thomas; Moreno, Victor; Kang, Taek Won; Cicin, Irfan; Girvin, Angela; Akapame, Sydney; O'Hagan, Anne; Zhu, Wei; Tammaro, Meggan; Thomas, Shibu; Triantos, Spyros; Siefker-Radtke, Arlene O

Efficacy of Immune Checkpoint Blockade in Advanced Upper Tract Urothelial Cancer With DNA Mismatch Repair Deficiency or Microsatellite Instability

免疫检查点阻断疗法治疗伴有DNA错配修复缺陷或微卫星不稳定性晚期上尿路尿路上皮癌的疗效

Moussa, Mohammad Jad; Andreev-Drakhlin, Alexander Y; Venkatesan, Aradhana M; Matin, Surena F; Xiao, Lianchun; Tidwell, Rebecca S S; Shah, Amishi Y; Adriazola, Ana C; Shaw, Leah; Gao, Jianjun; Lin, John K; Goswami, Sangeeta; Msaouel, Pavlos; Guo, Charles C; Tannir, Nizar M; Siefker-Radtke, Arlene O; Alhalabi, Omar; Campbell, Matthew T

Efficacy and safety of pembrolizumab in patients with advanced urothelial carcinoma deemed potentially ineligible for platinum-containing chemotherapy: Post hoc analysis of KEYNOTE-052 and LEAP-011

帕博利珠单抗治疗晚期尿路上皮癌患者(可能不适合接受含铂化疗)的疗效和安全性:KEYNOTE-052 和 LEAP-011 研究的事后分析

O'Donnell, Peter H; Loriot, Yohann; Csoszi, Tibor; Matsubara, Nobuaki; Shin, Sang Joon; Park, Se Hoon; Atduev, Vagif; Gumus, Mahmut; Karaca, Saziye Burcak; Grivas, Petros; de Wit, Ronald; Castellano, Daniel E; Powles, Thomas; Vuky, Jacqueline; Zhao, Yujie; O'Hara, Karen; Okpara, Chinyere E; Franco, Sonia; Homet Moreno, Blanca; Żołnierek, Jakub; Siefker-Radtke, Arlene O

Histopathologic Progression and Metastatic Relapse Outcomes in Small Cell Neuroendocrine Carcinomas of the Urinary Tract

泌尿系统小细胞神经内分泌癌的组织病理学进展和转移复发结果

Moussa, Mohammad Jad; Tabet, Georges C; Siefker-Radtke, Arlene O; Xiao, Lianchun; Wilson, Nathaniel R; Gao, Jianjun; Logothetis, Christopher J; Grivas, Petros; Lee, Byron; Shah, Amishi Y; Msaouel, Pavlos; Li, Roger; Clemente, Leticia Campos; Zhao, Jianping; Tannir, Nizar M; Kamat, Ashish M; Hansel, Donna E; Guo, Charles C; Campbell, Matthew T; Alhalabi, Omar

Plain language summary of the THOR Cohort 1 study comparing treatment with erdafitinib or chemotherapy in advanced or metastatic urothelial cancer

THOR 队列 1 研究的简明语言摘要:比较厄达替尼或化疗治疗晚期或转移性尿路上皮癌的疗效

Loriot, Yohann; Triantos, Spyros; Deprince, Kris; Siefker-Radtke, Arlene O

A Pilot Study of the CD38 Antagonist Daratumumab in Patients with Metastatic Renal Cell Carcinoma or Muscle-Invasive Bladder Cancer

CD38拮抗剂达雷妥尤单抗治疗转移性肾细胞癌或肌层浸润性膀胱癌患者的初步研究

Campbell, Matthew T; Shah, Amishi Y; Msaouel, Pavlos; Tannir, Nizar M; Siefker-Radtke, Arlene O; Kamat, Ashish M; Navai, Neema; Dinney, Colin P N; Rao, Priya; Guo, Charles C; Sheth, Rahul A; Venkatesan, Aradhana M; Tidwell, Rebecca S; Yadav, Shalini S; Gu, Aidi; Chen, Hong; Macaluso, Marc; Duan, Fei; Basu, Sreyashi; Jindal, Sonali; Sharma, Padmanee

Outcomes of Patients with Advanced Urothelial Carcinoma after Anti-programmed Death-(ligand) 1 Therapy by Fibroblast Growth Factor Receptor Gene Alteration Status: An Observational Study

成纤维细胞生长因子受体基因改变状态与接受抗程序性死亡配体1治疗的晚期尿路上皮癌患者预后的关系:一项观察性研究

Rezazadeh Kalebasty, Arash; Benjamin, David J; Loriot, Yohann; Papantoniou, Dimitrios; Siefker-Radtke, Arlene O; Necchi, Andrea; Naini, Vahid; Carcione, Jenna Cody; Santiago-Walker, Ademi; Triantos, Spyros; Burgess, Earle F

Management of Fibroblast Growth Factor Inhibitor Treatment-emergent Adverse Events of Interest in Patients with Locally Advanced or Metastatic Urothelial Carcinoma

成纤维细胞生长因子抑制剂治疗中局部晚期或转移性尿路上皮癌患者出现值得关注的不良事件

Siefker-Radtke, Arlene O; Necchi, Andrea; Park, Se Hoon; García-Donas, Jesús; Huddart, Robert A; Burgess, Earle F; Fleming, Mark T; Rezazadeh Kalebasty, Arash; Mellado, Begoña; Varlamov, Sergei; Joshi, Monika; Duran, Ignacio; Tagawa, Scott T; Zakharia, Yousef; Qi, Keqin; Akapame, Sydney; Triantos, Spyros; O'Hagan, Anne; Loriot, Yohann

Bempegaldesleukin plus nivolumab in first-line renal cell carcinoma: results from the PIVOT-02 study

贝培加地白介素联合纳武利尤单抗一线治疗肾细胞癌:PIVOT-02 研究结果

Tannir, Nizar M; Cho, Daniel C; Diab, Adi; Sznol, Mario; Bilen, Mehmet A; Balar, Arjun V; Grignani, Giovanni; Puente, Erika; Tang, Lily; Chien, David; Hoch, Ute; Choudhury, Arkopal; Yu, Danni; Currie, Sue L; Tagliaferri, Mary A; Zalevsky, Jonathan; Siefker-Radtke, Arlene O; Hurwitz, Michael E

Erdafitinib for locally advanced or metastatic urothelial carcinoma

厄达替尼用于治疗局部晚期或转移性尿路上皮癌

Siefker-Radtke, Arlene O; Loriot, Yohann